type full_text History And Physical Findings 89/Chi/MNKDAADL I, community ambulantPMHx 1. Hypertension 2. Hyperlipidaemia 3. Old CVA with good functional recovery, prev on aspirin last CT brain in Aug '07: recent infarcts in L external capsule and temporal lobe no previous TCD/ECD 4. Cardiac ulcer and hyperplastic polyp s/p polypectomy in 2001 presented with malaena and hemetemesis 5. Thiazide induced electrolyte imbalance in [REDACTED_NUMBER]. Atypical chest pain last MIBI in Sept '10: normal LVEF and coronary flow reserve 7. Vitamin B 12 deficiency noted during admission to cardiology in Sept '10 antiparietal cell Ab and anti IF positive on regular IM B 12 injection 8. L cataract s/p phaco and IOL (Jan 2015) 9. Haemorrhoids colono done in 2015 10. Cataract s/p R phacoPCChest pain ~2 am Presented to GP ClinicCPR 5 min 1 st rhythm VF > 1 x shock > ROSC > SCDF brought to NTFGH Started Amiodarone 300 mg/8 h NTF EMD. No loading doseDAPT ASA 300 Tica 180 given NTFGH Transferred to NUH for PPCI Patient intubated and sedated in CCUCOVID related hx from daughter in lawNo recent travel overseasNo fever or URTI/LRTI sx No contacts with known COVID patientsNo contacts with known existing clustersIssues 1. Out of hospital VF collapse due to Inferior STEMI Coros 20/3/20 LM normalLAD calcified 75 diffuse ostial LAD and 75 mid LAD lesion LCx minor diseaseRCA 100 RPDA occlusions/p POBA of 100 RPDA occlusion 20/3/20 (stent not deployed in view of small RPDA)s/p staged PCI DES of LM LAD on 23/3/20 required IABP support in CCU TTE EF 38 , multiple RWMA, PASP 49. IDC dilated and non compressible initially on DAPT aspirin tica > then switched to plavix rivaroxaban in view of AF for 1 year plavix rivaroxaban, then rivaroxaban life long 2. Post MI AF with sinus pause CHADSVASC 6 s/p VVIR PPM inserted on 25/3/20 completed 5/7 of empiric augmentin for device implantation started on rivaroxaban 3. AoCKD baseline Cr 120 s, highest 167 inpatient, down to 121 on discharge 4. Fever, no clear localising source cultures negative, CXR subtle air space opacities in right lower zone TW 11.24, CRP 70, Procal 0.25 empirically covered with Augmentin afebrile on discharge 5. CVRF: impaired fasting glycaemia, HLD LDL 2.78, TG 0.69 fasting glu 6.1, HbA1c 5.9 6. RehabST: initially required NGT, weaned off, on FM diet and thin fluids on discharge > ST will check in with family regarding swallowing end of week, if tolerating well at home, does not need further reviewsPT: safe for homeOT: safe for homeDietician: reviewed 7. Poor skin condition over forearm regular dressings to forearm 8. Known pernicious anaemia Hb stable inpatient Hb 11.3 on discharge PlanTCU 10 14 days arrythmia nurseTCU 4/52 to 6/52 Dr [REDACTED] [REDACTED] [REDACTED][REDACTED] [REDACTED] clinic x 1/12, FBC, RP, LPM, fasting glu√Ç OA TCU dietician x 1 2/12 Outcome Followup Plan TCU 10 14 days arrythmia nurseTCU 4/52 to 6/52 Dr [REDACTED] [REDACTED] [REDACTED][REDACTED] [REDACTED] clinic x 1/12, FBC, RP, LPM, fasting glu OATCU dietician x 1 2/12